Sandoz
Clinical trials sponsored by Sandoz, explained in plain language.
-
Could a cheaper copy of ocrevus work just as well for MS?
Disease control OngoingThis phase 3 trial tests whether CYB704, a proposed biosimilar to the MS drug Ocrevus, works the same way in the body. About 183 people with relapsing multiple sclerosis will receive either CYB704 or Ocrevus. Researchers will compare drug levels, MRI scans, and side effects to se…
Phase: PHASE3 • Sponsor: Sandoz • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Asthma inhaler showdown: generic vs. Brand-Name – study pulled before start
Disease control TerminatedThis study aimed to see if a generic version of the fluticasone furoate/vilanterol inhaler (Sandoz) works as well as the brand-name Breo Ellipta in adults with asthma. Participants would have stopped their usual asthma meds and used only the study inhaler or a placebo for 4 weeks…
Phase: PHASE3 • Sponsor: Sandoz • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New study tracks IBD patients on biosimilar drug hyrimoz®
Knowledge-focused OngoingThis study observes 562 adults with inflammatory bowel disease (Crohn's disease or ulcerative colitis) who are starting or switching to Hyrimoz®, a biosimilar of adalimumab. Researchers will track how many patients continue the treatment after 6 months and why some stop, such as …
Sponsor: Sandoz • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC